Iradimed Co Stock Price on January 3, 2025

IRMD Stock  USD 52.50  0.35  0.66%   
If you're considering investing in Iradimed Stock, it is important to understand the factors that can impact its price. As of today, the current price of Iradimed stands at 52.50, as last reported on the 21st of March, with the highest price reaching 53.36 and the lowest price hitting 51.81 during the day. Iradimed holds Efficiency (Sharpe) Ratio of -0.0149, which attests that the entity had a -0.0149 % return per unit of risk over the last 3 months. Iradimed exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Iradimed's Standard Deviation of 1.84, market risk adjusted performance of 9.33, and Risk Adjusted Performance of (0.01) to validate the risk estimate we provide.
  
Iradimed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0149

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIRMD

Estimated Market Risk

 1.84
  actual daily
16
84% of assets are more volatile

Expected Return

 -0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Iradimed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iradimed by adding Iradimed to a well-diversified portfolio.

Related Headline

Sight Sciences Headline on 3rd of January 2025

Filed transaction by Sight Sciences Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Iradimed Valuation on January 3, 2025

It is possible to determine the worth of Iradimed on a given historical date. On January 3, 2025 Iradimed was worth 54.75 at the beginning of the trading date compared to the closed value of 55.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Iradimed stock. Still, in general, we apply an absolute valuation method to find Iradimed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Iradimed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Iradimed's related companies.
 Open High Low Close Volume
  54.98    55.21    54.06    54.77    28,512  
01/03/2025
  54.75    55.60    54.34    55.35    29,222  
  55.93    56.83    55.53    56.32    24,239  
Backtest Iradimed  |  Iradimed History  |  Iradimed Valuation   PreviousNext  
Open Value
54.75
55.35
Closing Value
60.26
Upside

Iradimed Trading Date Momentum on January 3, 2025

On January 06 2025 Iradimed Co was traded for  56.32  at the closing time. The top price for the day was 56.83  and the lowest listed price was  55.53 . The trading volume for the day was 24.2 K. The trading history from January 6, 2025 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 1.75% . The trading delta at closing time against the current closing price is 1.66% .

Iradimed Fundamentals Correlations and Trends

By evaluating Iradimed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Iradimed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Iradimed financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Iradimed Stock history

Iradimed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iradimed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iradimed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iradimed stock prices may prove useful in developing a viable investing in Iradimed
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devices, and related accessories and services in the United States and internationally. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. Iradimed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 110 people.

Iradimed Stock Technical Analysis

Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Iradimed technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Iradimed trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Iradimed Period Price Range

Low
March 21, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Iradimed Co cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Iradimed March 21, 2025 Market Strength

Market strength indicators help investors to evaluate how Iradimed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iradimed shares will generate the highest return on investment. By undertsting and applying Iradimed stock market strength indicators, traders can identify Iradimed Co entry and exit signals to maximize returns

Iradimed Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Iradimed's price direction in advance. Along with the technical and fundamental analysis of Iradimed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iradimed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Iradimed Stock analysis

When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
CEOs Directory
Screen CEOs from public companies around the world